Prospective Validation of Clini-biological Parameters Including Initial Hemostasis, Which Improve the Prediction of Death at 1 Month Among Patients With Septic Shock
SEPSICOAG
Evaluation and Prospective Validation of Clini-biological Parameters Including Initial Hemostasis, Which Improve the Prediction of Death at 1 Month Among Patients Entering Intensive Care Units for Septic Shock
2 other identifiers
observational
780
1 country
7
Brief Summary
A prognostic score was proposed by the investigative team to predict death at 1 month. This score is based on certain biological markers, scored under emergency conditions in the first 24 hours of routine clinical practice management for septic shock. The main objective of this multicenter study is to validate the performance of the score in terms of area under the ROC curve and negative predictive value.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2009
Longer than P75 for all trials
7 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2009
CompletedFirst Submitted
Initial submission to the registry
October 29, 2010
CompletedFirst Posted
Study publicly available on registry
November 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
October 30, 2013
CompletedNovember 17, 2025
March 1, 2015
4.6 years
October 29, 2010
November 14, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
AUC of the studied prognostic score
The biological parameters measured at the time of admission to the intensive care unit and that make up the prognostic score for death at 1 month will be collected. The event "death within 1 month" will be analyzed. For patients discharged from service before the end of the first month, the clinician will still be informed concerning possible death. The studied biological parameters correspond to routine coagulation and hematological parameters for patients in septic shock, according to SFAR (Société Française d'Anesthésie et de Réanimation) recommendations and the SRLF (Société de Réanimation de Langue Française) Consensus (2002).
24 hours (studied score parameters); 1 month (mortality)
Negative predictive value of the studied prognostic score
The biological parameters measured at the time of admission to the intensive care unit and that make up the prognostic score for death at 1 month will be collected. The event "death within 1 month" will be analyzed. For patients discharged from service before the end of the first month, the clinician will still be informed concerning possible death. The studied biological parameters correspond to routine coagulation and hematological parameters for patients in septic shock, according to SFAR (Société Française d'Anesthésie et de Réanimation) recommendations and the SRLF (Société de Réanimation de Langue Française) Consensus (2002).
24 hours (studied score parameters); 1 month (mortality)
Secondary Outcomes (4)
AUC of the studied prognostic score
24 hours (studied score parameters); 1 week (mortality)
Negative predictive value of the studied prognostic score
24 hours (studied score parameters); 1 week (mortality)
AUC of the studied prognostic score
24 hours (studied score parameters); 5 days (DIC)
Negative predictive value for the studied prognostic score
24 hours (studied score parameters); 5 days (DIC)
Study Arms (1)
Septic shock patients
Interventions
Bilirubinemia (total and conjugated), hematology, hemogram, SOFA score
Eligibility Criteria
Severe septic shock patients entering intensive care units in the participating centers.
You may qualify if:
- patient (or representative) received the information notice
- patient has hemodynamic insufficiency of non-traumatic or cardiogenic origin associated with severe sepsis (treated with Noradrenalin) and organ dysfunction, hypoperfusion or hypotension
- body temperature \> 38.3°C or \< 36°C
- heart rate \> 90 bpm
- Tachypnea \> 20 C/min or PaCO2 \< 32 mmHg or mechanical ventilation
- leukocytes \> 12000 µL-1 ou \< 4000 µL-1 ou \> 10% immature forms
- oliguria \< 0.5 ml/kg/h for at least 2 hours
- abrupt alteration (24 h) of conscienceness
- thrombocytopenia \< 100 000 G/L or disseminated intravascular coagulation
- mottled skin and / or capillary refill time\> 3 sec
- PaO2/FiO2 \< 300 mmHg ou \< 40KPas
- Lactatemia \> 2mMol/l
- septic shock: Systolic Blood Pressure (SBP) \> 90 mmHg or need for vasopressors to maintain SBP\> 90 mmHg despite a prior filling (20-30 ml / kg of macromolecules or 40 to 60 ml / kg of normal saline (or decrease in SBP\> 40% in the hypertensive)
You may not qualify if:
- patient is dying or limitation or cessation of active treatment
- patient is already included in another trial
- patient or family refusal
- patient not affiliated with a social security system
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (7)
CHU de Clermont Ferrand - Hôpital Estaing
Clermont-Ferrand, 63003, France
APHM - Hôpital de la Conception
Marseille, 13385, France
AP-HM Hôpital Nord
Marseille, 13915, France
Centre Hospitalier Universitaire de Montpellier
Montpellier, France
CHU de Nice
Nice, France
Centre Hospitalier Universitaire de Nîmes
Nîmes, 30029, France
CHU de Saint Etienne
Saint-Etienne, 42055, France
Related Publications (1)
Gris JC, Faillie JL, Cochery-Nouvellon E, Lissalde-Lavigne G, Lefrant JY. ISTH overt disseminated intravascular coagulation score in patients with septic shock: automated immunoturbidimetric soluble fibrin assay vs. D-dimer assay. J Thromb Haemost. 2011 Jun;9(6):1252-5. doi: 10.1111/j.1538-7836.2011.04270.x. No abstract available.
PMID: 21645228RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Géraldine Lavigne-Lissalde, MD
Centre Hospitalier Universitaire de Nîmes
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 29, 2010
First Posted
November 1, 2010
Study Start
April 1, 2009
Primary Completion
October 30, 2013
Study Completion
October 30, 2013
Last Updated
November 17, 2025
Record last verified: 2015-03